GlaxoSmithKline plans sale of $3.7-billion stake in Hindustan Unilever

The firm may offload part or all of its 5.7% holding in HUL through a series of block trades

GlaxoSmithKline is preparing to start a sale of its $3.7 billion stake in Unilever’s listed India unit, according to people familiar with the matter.
 

Glaxo plans to offload part or all of its 5.7% holding in Hindustan Unilever (HUL) through a series of block trades, which could start as soon as the next few days, according to the people.
 

The firm is in discussions with advisors on when to launch the transactions, the people said, asking not to be identified because the information is private.

The